Cytotoxic factor as is associated with multiple sclerosis, its detection and its quantification
US5876954A · kind A · utility
8Cited by
12References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 15, 1995 |
| Grant date | Mar 2, 1999 |
| Priority date | — |
| Expiry date | Feb 15, 2015 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/828
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Gliotoxic factor in the isolated or purified state, characterized in that it possesses toxic activity with respect to human or animal astrocytic cells, having the effect of a cytomorphological disorganization of their network of intermediate filaments and/or a degradation of the proteins of said intermediate filaments and/or cell death, in particular by apoptosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.